Showing results (381-390 of 501) with videos related to

Sort By:
Pageof 51
BMJ Neurology Open|July 12, 2021
Cognitive function in men with non-motor features of Parkinson's diseaseMario H Flores-Torres, Katherine C Hughes, Samantha Molsberry, et al.
BMJ Neurology Open|July 12, 2021
Incidence of idiopathic intracranial hypertension in Southern Tasmania, AustraliaNatasha Krishnadas, Bruce Taylor
BMJ Neurology Open|June 20, 2022
Chronic lesion activity and disability progression in secondary progressive multiple sclerosisVanessa Beynon, Ilena C George, Colm Elliott, et al.
BMJ Neurology Open|June 3, 2021
Acute flaccid myelitis: long-term outcomes recorded in the CAPTURE study compared with paediatric transverse myelitisBenjamin Greenberg, Patricia Plumb, Gary Cutter, et al.
BMJ Neurology Open|February 7, 2022
Longitudinal changes of early motor and cognitive symptoms in progressive supranuclear palsy: the OxQUIP studyMarta F Pereira, Tim Buchanan, Günter U Höglinger, et al.
BMJ Neurology Open|April 11, 2022
Coexistent anti-GFAP and anti-MOG antibodies presenting with isolated meningitis and papillitis: more support for overlapping pathophysiologyAndrew J Martin, James Strathdee, Nigel Wolfe
BMJ Neurology Open|July 20, 2022
Guillain-Barré syndrome following SARS-CoV-2 vaccination in the UK: a prospective surveillance studyArina A Tamborska, Bhagteshwar Singh, Sonja E Leonhard, et al.
BMJ Neurology Open|April 25, 2022
Prognosis and antiplatelet therapy of small single subcortical infarcts in penetrating artery territory: a post hoc analysis of the Third China National Stroke RegistryYu-Yuan Xu, Jing Jing, Yi-Jun Zhang, et al.
BMJ Neurology Open|March 10, 2022
Nrf2 activation in the human brain after stroke due to supratentorial intracerebral haemorrhage: a case-control studyEdward Christopher, James J M Loan, Neshika Samarasekera, et al.
BMJ Neurology Open|November 29, 2023
Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA-associated Parkinson's disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocolFabiana Colucci, Micol Avenali, Rosita De Micco, et al.
Pageof 51